The cockpit aligned to how a person actually works a decision — ordered paths from a starting question to an outcome. Pick a role, follow the steps; every page shows where you are and what's next.
The UFlex thesis: shift the mix from cyclical commodity films to value-added — Asepto, specialty & PCR — the four pillars, the value levers, how the group is performing, the P&L & cash, the margin journey by business, and the shareholder value it creates.
Lift the films business above the commodity cycle — Alox, high-barrier and PCR specialty films plus recycling leadership: where the demand signals are, the capex behind them, the businesses they join, the program book, qualification with global CPGs, and how they lift blended margin.
Earnings to cash to value: the consolidated P&L, resin-cost & inventory working capital, the deleverage path off 4.35× net debt/EBITDA after the capex cycle, business economics, and the listed-company valuation view.
Is the thesis compounding shareholder value: the data mesh behind the numbers, the three lenses, the footprint, the deleverage & margin levers, and the market-cap / EV bridge behind the ~0.22×-sales re-rating case.
Run and grow the nine-country films network and convert demand into a durable book: the order book & demand by region, CPG accounts & cross-business reach, orders & specs, value-added programs & repeat volumes, delivery, and order → cash.
Sense → decide → act across the films lines, converting plants and Asepto: the towers, the agents that act, delivery & quality, the workforce, and resin & supply risk.
The UFlex thesis: shift the mix from cyclical commodity films to value-added — Asepto, specialty & PCR — the four pillars, the value levers, how the group is performing, the P&L & cash, the margin journey by business, and the shareholder value it creates.
Lift the films business above the commodity cycle — Alox, high-barrier and PCR specialty films plus recycling leadership: where the demand signals are, the capex behind them, the businesses they join, the program book, qualification with global CPGs, and how they lift blended margin.
Earnings to cash to value: the consolidated P&L, resin-cost & inventory working capital, the deleverage path off 4.35× net debt/EBITDA after the capex cycle, business economics, and the listed-company valuation view.
Is the thesis compounding shareholder value: the data mesh behind the numbers, the three lenses, the footprint, the deleverage & margin levers, and the market-cap / EV bridge behind the ~0.22×-sales re-rating case.
Run and grow the nine-country films network and convert demand into a durable book: the order book & demand by region, CPG accounts & cross-business reach, orders & specs, value-added programs & repeat volumes, delivery, and order → cash.
Sense → decide → act across the films lines, converting plants and Asepto: the towers, the agents that act, delivery & quality, the workforce, and resin & supply risk.